Is 1,200 calories a day enough on Wegovy or Zepbound?

No source sets 1,200 calories as a safe minimum for everyone. A 2025 joint advisory from four medical societies says vitamin and mineral shortfalls become more likely below about 1,200 calories a day for women and 1,800 for men. Ask your prescriber or a registered dietitian what intake fits you.

Do you have to count calories on a GLP-1 drug?

The FDA labels say the drugs are used with a reduced-calorie diet and more physical activity. They do not require calorie counting. The main trials gave participants a target of about 500 calories a day below their needs, with regular counseling.

How much of the weight lost on semaglutide is muscle?

In the STEP 1 trial, 38% of the weight lost was lean body mass, which includes muscle and other non-fat tissue. The 2025 joint advisory estimates that muscle made up about 20% of the total weight lost. The advisory says strength training and adequate protein help to preserve muscle.

Should you take a multivitamin on a GLP-1 medication?

The 2025 joint advisory says supplements can be considered for at-risk nutrients such as vitamin D, calcium and vitamin B12. It says the choice should match each person's needs. Talk with your prescriber or a dietitian before you start one.

Can eating too little on a GLP-1 drug cause gallstones?

Both drug labels warn about gallbladder disease. The Wegovy label says substantial or rapid weight loss can raise the risk. NIDDK says long periods without eating and fast weight loss make the liver release extra cholesterol into bile, which can form stones.

How Many Calories Should You Eat on a GLP-1 Medication Like Wegovy or Zepbound?

The short answer: No official calorie number exists for people on Wegovy or Zepbound. The FDA labels say the drugs are used with a reduced-calorie diet, and the main trials told participants to eat about 500 calories a day below their needs. A 2025 advisory from four medical societies warns that nutrient shortfalls become more likely below about 1,200 calories a day for women and 1,800 for men. Your own target should come from your prescriber or a registered dietitian.

What do the Wegovy and Zepbound labels say about calories?

Both labels tie the drug to diet. The Wegovy label says semaglutide is indicated "in combination with a reduced calorie diet and increased physical activity." The Zepbound label uses similar wording for tirzepatide.

Neither label gives a calorie number in its dosing instructions. The numbers appear only in the section that describes the clinical trials. That section reports what study participants were told to do. It is a record of the trial design, and the label does not present it as an instruction for every patient.

What calorie deficit did the trials use?

The main trials used a modest deficit. The Wegovy label says participants in most of its weight-reduction studies "received instruction for a reduced-calorie diet (approximately 500 kcal/day deficit)" plus at least 150 minutes of physical activity a week. That group includes STEP 1, the 68-week trial of 1,961 adults.

The Zepbound label describes the same approach for its two main weight-reduction trials: a reduced-calorie diet with a deficit of about 500 calories a day and at least 150 minutes of weekly activity. The first of those trials is SURMOUNT-1, which ran for 72 weeks.

Two points matter here:

The deficit was relative. A 500-calorie deficit is measured against the calories a person burns. It gives a different intake for each person. If you do not know your starting point, our guide on how to calculate TDEE explains the estimate.
The instruction is not the same as the intake. The labels report what participants were told. They do not report what participants ate once the drug reduced their appetite.

The joint advisory cites research in which people on these drugs cut their energy intake by 16% to 39%. For many people that is a larger gap than 500 calories.

Does any guideline set a calorie floor?

We found no guideline that sets a minimum calorie intake for people on GLP-1 drugs. The labels do not set one. The joint advisory does not set one either.

The closest statement is a caution. The 2025 joint advisory came from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. It says a large, rapid drop in intake "can produce insufficient intake of essential vitamins and minerals, especially at energy intakes <1200 kcal/day for women and <1800 kcal/day for men."

That sentence describes where risk rises. It is a warning level for nutrient shortfalls, and the authors do not call it a required minimum.

The labels also show that lower intakes were used in some trials, under supervision:

One Wegovy study started with an 8-week low-calorie diet of 1,000 to 1,200 calories a day. It then moved to 1,200 to 1,800 calories a day for 60 weeks.
One Zepbound study had a 12-week lead-in led by a dietitian. Participants were told to eat about 1,200 calories a day (women) or 1,500 calories a day (men).

Those diets came with regular counseling from trial staff. They are not a model for an unsupervised diet at home.

How much protein do you need on a GLP-1 drug?

The advisory gives ranges, and it says experts have not agreed on one method. The figures it reports are:

0.8 grams per kilogram of body weight per day: the standard recommended dietary allowance for adults.
1.2 to 1.6 grams per kilogram per day: a higher target proposed for active weight reduction.
80 to 120 grams per day: a simple absolute target that the authors say "may enhance adherence while ensuring adequate intake."

The advisory adds a caution about body weight. For a person with obesity, a target based on actual weight "can significantly overestimate protein requirements." Adjusted weight or fat-free mass may give a better number, but the authors say there is no consensus.

The advisory also sets an upper limit. It says prolonged intake above 2 grams per kilogram per day should be avoided.

Low appetite makes protein hard to reach. The advisory suggests that people eat protein-rich foods first in a meal. Our protein intake guide covers food sources and how to spread protein across the day.

What happens if you eat too little?

The sources describe three risks.

Lean mass loss. The advisory reports body composition data from STEP 1. Of an average 13.6 kg lost, 8.3 kg (62%) was fat and 5.3 kg (38%) was lean body mass. Lean mass includes muscle and other non-fat tissue. The authors estimate that muscle made up about 20% of the total weight lost.

The advisory says lean mass loss depends on the degree of calorie restriction, the speed of weight loss and whether a person does strength training. Low protein intake from a reduced appetite may add to the loss. The authors name resistance training and an appropriate diet as the ways to preserve muscle and bone. We cover the methods in preserving muscle in a calorie deficit.

Nutrient shortfalls. Less food means fewer vitamins and minerals. The advisory lists signs of deficiency: unusual fatigue, heavy hair loss, flaky or itchy skin, muscle weakness, poor wound healing and unusual bruising. It says supplements "can be proactively considered for at-risk nutrients, such as vitamin D, calcium, and B12," matched to each person.

Gallstones. Both labels carry a warning about acute gallbladder disease. In adult weight-reduction trials, gallstones were reported in 1.6% of people on Wegovy injection and 0.7% on placebo. The Zepbound label reports 1.1% on the drug and 1% on placebo, and it states that gallbladder events "were associated with weight reduction."

The Wegovy label tells patients that substantial or rapid weight loss can raise the risk of gallbladder disease. It adds that the disease can also occur without rapid weight loss. NIDDK explains the mechanism: when you go a long time without eating or lose weight quickly, the liver releases extra cholesterol into bile. Fast weight loss can also stop the gallbladder from emptying properly.

For more on how these drugs work, see our sibling site glp1.md.

When should you see a registered dietitian?

The advisory names counseling from a registered dietitian nutritionist as a supportive strategy for people on GLP-1 drugs. It says this counseling should support medication adherence, help prevent or manage stomach and bowel side effects, and promote adequate nutrient intake. It notes that side effects are a particular concern when the drug is started and when the dose goes up.

Based on the risks the sources describe, a dietitian visit or a call to your prescriber makes sense in these cases:

You are starting the drug and do not have an eating plan.
Nausea or low appetite stops you from eating regular meals.
You cannot reach your protein target.
You have signs of deficiency, such as heavy hair loss, weakness or unusual fatigue.
You have diabetes, kidney disease or a history of disordered eating.

The advisory recommends that screening before treatment cover usual eating habits and disordered eating. Both labels tell patients to contact their healthcare provider if gallbladder disease is suspected.

The bottom line

No source gives one calorie number for people on Wegovy or Zepbound. The trials behind both drugs told participants to eat about 500 calories a day below their needs. No guideline sets a calorie floor, but the 2025 joint advisory warns that nutrient shortfalls become more likely below about 1,200 calories a day for women and 1,800 for men.

The same advisory reports protein targets of 1.2 to 1.6 grams per kilogram per day, or 80 to 120 grams per day, during weight loss. It pairs protein with resistance training to protect muscle. Ask your prescriber or a registered dietitian to set your own numbers.

Last updated: October 2026. This article is for informational purposes only and does not constitute medical advice. Talk with your prescriber or a registered dietitian before you change your calorie or protein intake while taking a GLP-1 medication.